FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:305-307 January 19, 2006 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Robinson, B. W.S. PubMed Citation

To the Editor: In their review article, Robinson and Lake (Oct. 13 issue)¹ write that membranous immunoreactivity of malignant cells in effusions with epithelial membrane antigen (EMA) is highly suggestive of malignant mesothelioma. If this were true, then the cytologic diagnosis of mesothelioma would be far less challenging than is the case in current practice. Not all malignant mesotheliomas are EMA-positive.² Moreover, reactive mesothelial cells may demonstrate membranous staining with EMA, albeit in only 3 to 4 percent of cases.³ Finally, some adenocarcinomas (14 percent) may also have a membranous EMA staining pattern.⁴ The experience of several experts in the . . . [Full Text of this Article]

This article has been cited by other articles:

• Nguyen, D., Lee, S.-J., Libby, E., Verschraegen, C. (2008). Rate of Thromboembolic Events in Mesothelioma. Ann. Thorac. Surg. 85: 1032-1038 [Abstract] [Full Text]